|
BIOSENSE WEBSTER INC OCTARAY MAPPING CATHETER; CATHETER, INTRACARDIAC MAPPING, HIGH-DENSITY ARRAY
|
Back to Search Results |
|
| Catalog Number |
D160904 |
| Medical Device Problem Code |
Patient Device Interaction Problem (4001)
|
| Health Effect - Clinical Code |
Ischemic Heart Disease (2493)
|
| Date of Event |
11/18/2024
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
D4: udi: the manufacturing and expiration dates are currently not available.Therefore, the full udi is currently not available.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
|
| |
|
Event or Problem Description
|
|
It was reported that a patient underwent a cardiac ablation and the patient experienced st elevation that required medication.The patient presented a small elevation of the st before the beginning of the procedure.During the mapping phase, the st was worsening, and so, nitroglyceride puff was applied.The procedure was continued; however, the st did not improve after the application of nitroglyceride and the ventricular extrasystole ablation procedure was completed.Therefore, it was decided to call the hemodynamics specialist who performed a diagnostic catheterization without observing anything relevant.It is important to mention that during the injection of contrast in the right coronary artery, no anomalies were observed but the st was recovered to normal levels.
|
| |
|
Additional Manufacturer Narrative
|
|
The device investigation has been completed which included performing a manufacturing record evaluation (mre).The manufacturing record evaluation was performed for the finished device number lot 31350316l, and no internal action related to the complaint was found during the review.Additionally, the manufacture and expiration dates have been provided.Therefore, fields d4.Expiration date and h4.Device manufacture date have been populated.Since no device has been received for analysis, no product investigation can be performed, and the customer complaint cannot be confirmed.However, if the product is received at a later date, the investigation will be updated as applicable.As part of our company quality system process, all devices are manufactured, inspected, and distributed to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
| |
|
Search Alerts/Recalls
|
|
|